Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nyse  >  Pfizer Inc.    PFE

PFIZER INC.

(PFE)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Pfizer : First batch of Pfizer vaccines arrive in Lebanon

02/13/2021 | 12:36pm EST

BEIRUT (AP) — Lebanon received its first batch of coronavirus vaccines Saturday ahead of a nationwide campaign to start vaccinations in the tiny Mediterranean country, which has seen a sharp rise in cases and fatalities in recent weeks.

The 28,500 Pfizer doses from Brussels arrived on a plane from Lebanon's national carrier and were to be taken to the Health Ministry's warehouse, state-run National News Agency reported. From there, the vaccines will be sent to other parts of the country.

The first vaccinations are scheduled to take place in limited numbers on Sunday at four medical centers in the capital Beirut before the process begins in more than a dozen centers on Monday, local media reported. Within two weeks, the Health Ministry says 57 vaccination centers are to be set up nationwide.

Lebanon has registered more than 334,000 cases of coronavirus and 3,915 deaths since the country's first registered case in February last year.

Lebanon succeeded in containing the virus during the pandemic’s early months, but the numbers began to increase following a massive blast in the capital’s port in August, which caused widespread damage in the city. The number of cases and deaths hit record highs after an estimated 80,000 expats flowed to the country to celebrate Christmas and New Year's with loved ones.

Lebanon imposed a nationwide lockdown including a curfew as of Jan. 11 to try limit the spread of the virus.

More Pfizer doses are scheduled to arrive over the coming weeks and at a later stage AstraZeneca shots will be brought in, according to Abdul-Rahman Bizri, head of the national committee on COVID-19 vaccines.

So far, some 450,000 people have registered to take the vaccines, said Health Minister Hamad Hassan upon the shots’ arrival Saturday. The figure is still a small percentage of the country of around six million, including a million Syrian refugees.

The World Bank said last month it approved $34 million to help pay for vaccines for Lebanon that will inoculate over 2 million people.

World Bank Regional Director Saroj Kumar Jha told reporters in a virtual news conference in late January that Lebanon will import 1.5 million doses from Pfizer vaccines for 750,000 people “and this we are financing in full.” The World Bank will also help in financing other vaccines.

Lebanon is passing through its worst economic and financial crisis in its modern history, leaving half of its population below the poverty line. The vaccines will be free of charge for the public.

The plan will begin by vaccinating workers in the medical sector and people age 75 and above, as well as others with chronic diseases.

The World Bank and the International Federation of the Red Cross and Red Crescent Societies signed an agreement on Saturday for independent monitoring of Lebanon’s coronavirus vaccination campaign.

Copyright 2021 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed without permission., source Associated Press News

All news about PFIZER INC.
12:42aBIONTECH  : Brazil In Talks for More AstraZeneca, BioNTech Pfizer COVID-19 Vacci..
MT
03/08TERUMO  : Japan's Terumo says makes syringe to draw 7 doses from Pfizer vaccine ..
RE
03/08Australia shares gain on hopes of swift passage for U.S. stimulus; tech stock..
RE
03/08PFIZER  : first expected vaccine wouldn't be approved in Canada until February
AQ
03/08US HEALTH AGENCY : Fully vaccinated people can gather indoors without masks
AQ
03/08MODERNA  : COVID SCIENCE-Vaccine response may be weaker in elderly; Merck drug s..
RE
03/08PFIZER  : NIH Starts Enrollment in Late-Stage Trial of Pfizer, Bristol Myers Blo..
MT
03/08MODERNA  : Fully vaccinated people can gather without masks indoors, should stil..
RE
03/08PFIZER  : Valneva Launch Mid-Stage Study on Lyme Disease Treatment Candidate
MT
03/08ETF PREVIEW : ETFs Mixed, Futures Higher After US Senate Passes $1.9 Trillion S..
MT
More news
Financials (USD)
Sales 2020 48 014 M - -
Net income 2020 16 066 M - -
Net Debt 2020 42 982 M - -
P/E ratio 2020 12,2x
Yield 2020 4,27%
Capitalization 192 B 192 B -
EV / Sales 2020 4,89x
EV / Sales 2021 3,70x
Nbr of Employees 88 300
Free-Float 59,0%
Chart PFIZER INC.
Duration : Period :
Pfizer Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends PFIZER INC.
Short TermMid-TermLong Term
TrendsBearishBearishNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 23
Average target price 41,04 $
Last Close Price 34,35 $
Spread / Highest target 54,3%
Spread / Average Target 19,5%
Spread / Lowest Target 4,80%
EPS Revisions
Managers and Directors
NameTitle
Albert Bourla Chairman, Chief Executive & Operating Officer
Frank A. D'Amelio Chief Financial Officer & EVP-Global Supply
Mikael Dolsten Chief Scientific Officer
Lidia L. Fonseca Executive VP, Chief Digital & Technology Officer
Aida Habtezion Chief Medical Officer
Sector and Competitors
1st jan.Capitalization (M$)
PFIZER INC.-6.68%191 650
JOHNSON & JOHNSON0.01%410 337
ROCHE HOLDING AG-3.56%274 753
ABBVIE INC.-0.97%188 420
ELI LILLY AND COMPANY22.62%187 971
NOVARTIS AG-8.08%186 338